Benzinga | Aug 13, 2021 04:56AM EDT

Keybanc Maintains Overweight on BioLife Solutions, Raises Price Target to $60

Keybanc analyst Paul Knight maintains BioLife Solutions (NASDAQ:BLFS) with a Overweight and raises the price target from $50 to $60.